Article Details

Next-gen Biomanufacturing Market Size to Reach US$39.4 Billion by 2032 | BioSpace

Retrieved on: 2024-06-12 01:37:31

Tags for this article:

Click the tags to see associated articles and topics

Next-gen Biomanufacturing Market Size to Reach US$39.4 Billion by 2032 | BioSpace. View article details on hiswai:

Summary

The article highlights the significance of next-gen biomanufacturing, emphasizing new technologies like continuous manufacturing and single-use systems, which enhance efficiency and adaptability. Driven by AI and advanced robotics, these advancements promise to transform the biotechnology, drug manufacturing, and pharmaceutical industries in various regions, particularly North America. The focus is on improved scalability, sustainability, and responding to market demands, reflecting the tags and the key concept. Tags: 'Biotechnology, Drug manufacturing, Biopharmaceuticals, Biomanufacturing, Food industry, Scale, Pharmaceutical industry in India, Contract manufacturing organization, Golden LEAF Biomanufacturing Training and Education Center, NCBioImpact'

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up